VIVO Financial Facts
GROSS PROFIT: 29.72MTotal other income (expense): -143K
See Full Income Statement
Accounts payable: 7.63M
Total current liabilities: -34.68M
See Full Balance Sheet
Meridian Bioscience Inc. (VIVO) Earnings
|
Expand Research on VIVO
| Next EPS Date | 8/31/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +39.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/31/26  |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 6/3/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 1/26/23 | Q123 | N/A | $0.20 | N/A | N/A | $72.3M | N/A | N/A | N/A | ||
| 11/14/22 | Q422 | N/A | $0.12 | N/A | N/A | $63M | = | N/A | N/A | ||
| 11/10/22 | Q422 | N/A | $0.20 | N/A | N/A | $71.95M | = | N/A | N/A | ||
| 8/5/22 | Q322 | $0.16 | $0.17 | -$0.01 | $67.8M | $66.8M | = |  | | Details | |
| 5/6/22 |  |
Q222 | $0.67 | $0.32 | +$0.35 | $111.2M | $83.29M | = | | | Details |
| 2/4/22 | |
Q122 | $0.35 | $0.25 | +$0.10 | $88.3M | $70.29M | = | | | Details |
